Recent findings indicate that treating pregnant women with opioid use disorder (OUD) using buprenorphine is associated with a reduced risk for fetal malformations compared with methadone.
“This is one of many important pieces of information that physicians and patients can use when determining the best treatment for opioid use disorder in pregnancy,” study author Elizabeth Suarez, PhD, MPH, a pharmacoepidemiologist at Rutgers Institute for Health, Health Care Policy, and Aging